The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Immune recognition of a human renal cancer antigen through post-translational protein splicing
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SYFPEITHI: database for MHC ligands and peptide motifs
Rammensee, H. G., Bachmann, J., Emmerich, N. P. N., Bachor, O. A., & Stevanović, S. (1999) · Immunogenetics · doi:10.1007/s002510050595 · Cited by 2,314
Steimle, V (1993) · Cell · doi:10.1016/0092-8674(93)90685-j · Cited by 864
Analysis of canonical and non-canonical splice sites in mammalian genomes
Burset, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.21.4364 · Cited by 619
Making sense of mass destruction: quantitating MHC class I antigen presentation
Yewdell, J. W., Reits, E., & Neefjes, J. (2003) · Nature Reviews Immunology · doi:10.1038/nri1250 · Cited by 445
Self-citationProtein Splicing and Related Forms of Protein Autoprocessing
Paulus, H. (2000) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.69.1.447 · Cited by 425
Polypeptide ligation occurs during post-translational modification of concanavalin A
Carrington, D. M., Auffret, A., & Hanke, D. E. (1985) · Nature · doi:10.1038/313064a0 · Cited by 254
Evolving questions and paradigm shifts in endoplasmic‐reticulum‐associated degradation (ERAD)
McCracken, A. A., & Brodsky, J. L. (2003) · BioEssays · doi:10.1002/bies.10320 · Cited by 221
A Persistent Untranslated Sequence Within Bacteriophage T4 DNA Topoisomerase Gene 60
Huang, W. M., Ao, S.-Z., Casjens, S., Orlandi, R., Zeikus, R., Weiss, R., Winge, D., & Fang, M. (1988) · Science · doi:10.1126/science.2830666 · Cited by 197
Mosse, C. A., Meadows, L., Luckey, C. J., Kittlesen, D. J., Huczko, E. L., Slingluff, C. L., Shabanowitz, J., Hunt, D. F., & Engelhard, V. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.37 · Cited by 127
Hanada, K., Perry-Lalley, D. M., Ohnmacht, G. A., Bettinotti, M. P., & Yang, J. C.-H. (2001) · PubMed · Cited by 75
Self-citation
Cited by
Towards a systems understanding of MHC class I and MHC class II antigen presentation
Neefjes, J., Jongsma, M. L. M., Paul, P., & Bakke, O. (2011) · Nature Reviews Immunology · doi:10.1038/nri3084 · Cited by 2,044
“Proteases usually cleave off protein fragments, but they can also ligate two peptides, as in the case of protein splicing by the 20S core of the proteasom”
BackgroundCohen, H. T., & McGovern, F. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043172 · Cited by 1,554
CELL BIOLOGY OF ANTIGEN PROCESSING IN VITRO AND IN VIVO
Trombetta, E. S., & Mellman, I. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104538 · Cited by 1,173
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Coulie, P. G., Van den Eynde, B. J., van der Bruggen, P., & Boon, T. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3670 · Cited by 1,138
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
Gros, A., Robbins, P. F., Yao, X., Li, Y. F., Turcotte, S., Tran, E., Wunderlich, J. R., Mixon, A., Farid, S., Dudley, M. E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73639 · Cited by 1,111
Self-citationNeoantigens: promising targets for cancer therapy
Xie, N., Shen, G., Gao, W., Huang, Z., Huang, C., & Fu, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01270-x · Cited by 1,020
More than one reason to rethink the use of peptides in vaccine design
Purcell, A. W., McCluskey, J., & Rossjohn, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2224 · Cited by 860
Robbins, P. F., Kassim, S. H., Tran, T. L. N., Crystal, J. S., Morgan, R. A., Feldman, S. A., Yang, J. C., Dudley, M. E., Wunderlich, J. R., Sherry, R. M., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2708 · Cited by 807
Self-citationA guide to antigen processing and presentation
Pishesha, N., Harmand, T. J., & Ploegh, H. L. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00707-2 · Cited by 805
HUMAN T CELL RESPONSES AGAINST MELANOMA
Boon, T., Coulie, P. G., Eynde, B. J. V. D., & Bruggen, P. V. D. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090733 · Cited by 651
Schumacher, T. N., Scheper, W., & Kvistborg, P. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053402 · Cited by 574
Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion
Delong, T., Wiles, T. A., Baker, R. L., Bradley, B., Barbour, G., Reisdorph, R., Armstrong, M., Powell, R. L., Reisdorph, N., Kumar, N., et al. (2016) · Science · doi:10.1126/science.aad2791 · Cited by 503
A listing of human tumor antigens recognized by T cells: March 2004 update
Novellino, L., Castelli, C., & Parmiani, G. (2005) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-004-0560-6 · Cited by 466
Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors
Leko, V., & Rosenberg, S. A. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.07.013 · Cited by 449
“The first such antigen to be identified was a peptide derived by joining two peptide fragments (a 5- and a 4-mer) that were separated by 40 amino acids in the parent protein encoded by FGF5, a gene that is frequently overexpressed in RCC (Hanada et al., 2004).”
BackgroundInfluentialLu, Y.-C., Yao, X., Crystal, J. S., Li, Y. F., El-Gamil, M., Gross, C., Davis, L., Dudley, M. E., Yang, J. C., Samuels, Y., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0433 · Cited by 401
Self-citationRecent advances in antigen processing and presentation
Jensen, P. E. (2007) · Nature Immunology · doi:10.1038/ni1516 · Cited by 382
Alternative tumour-specific antigens
Smith, C. C., Selitsky, S. R., Chai, S., Armistead, P. M., Vincent, B. G., & Serody, J. S. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0162-4 · Cited by 351
An Antigenic Peptide Produced by Peptide Splicing in the Proteasome
Vigneron, N., Stroobant, V., Chapiro, J., Ooms, A., Degiovanni, G., Morel, S., van der Bruggen, P., Boon, T., & Van den Eynde, B. J. (2004) · Science · doi:10.1126/science.1095522 · Cited by 330
MHC class Ib molecules bridge innate and acquired immunity
Rodgers, J. R., & Cook, R. G. (2005) · Nature Reviews Immunology · doi:10.1038/nri1635 · Cited by 323
The role of the proteasome in the generation of MHC class I ligands and immune responses
Sijts, E. J. A. M., & Kloetzel, P.-M. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0657-y · Cited by 280
A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion
Dersh, D., Hollý, J., & Yewdell, J. W. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-0390-6 · Cited by 278
Self-citationEfficient backbone cyclization of linear peptides by a recombinant asparaginyl endopeptidase
Harris, K. S., Durek, T., Kaas, Q., Poth, A. G., Gilding, E. K., Conlan, B. F., Saska, I., Daly, N. L., van der Weerden, N. L., Craik, D. J., et al. (2015) · Nature Communications · doi:10.1038/ncomms10199 · Cited by 257
Identification of tumor antigens with immunopeptidomics
Chong, C., Coukos, G., & Bassani-Sternberg, M. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01038-8 · Cited by 232
Zhang, B., & Bassani-Sternberg, M. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007073 · Cited by 44
Dendritic cells, DRiPs, and DALIS in the control of antigen processing
Pierre, P. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00300.x · Cited by 41
Learning from the Proteasome How To Fine-Tune Cancer Immunotherapy
Vigneron, N., Abi Habib, J., & Van den Eynde, B. J. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.07.007 · Cited by 33
Antigen presentation of post‐translationally modified peptides in major histocompatibility complexes
de Wit, A. S., Bianchi, F., & van den Bogaart, G. (2025) · Immunology & Cell Biology · doi:10.1111/imcb.12839 · Cited by 12
Metadata
- Authors
- Hanada, K.-I., Yewdell, J. W., & Yang, J. C.
- Venue
- Nature
- Published
- 2004-01
- Volume
- 427
- Issue
- 6971
- Pages
- 252-256
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2074345036
- Cited by
- 336
- References
- 12
- FWCI
- 10.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.